International Journal of Surgical Oncology / 2011 / Article / Tab 5

Review Article

Lymph Node Dissection in Curative Gastrectomy for Advanced Gastric Cancer

Table 5

Randomized controlled trials comparing D2 with D2 plus para-aortic lymph nodes.

StudyCountryComparisonPostoperative
morbidity
Postoperative
mortality
5-year survival

JCOG trial
(1995–2001)
JapanD2
D2+ PALN
20.9%
28.1%
0.8%
0.8%
69.2%
70.3%
HR 1.03
(95% CI, 0.77–1.37)
Polish trial
(1999–2003)
PolandD2
D2+ PALN
27.7%
21.6%
4.9%
2.2%
Under analysis
East Asian trial
(1995–2002)
Japan, Korea, and Chinese Taiwan areaD2
D2+ PALN
26%
39%
0.7%
3.7%
52.6%
55.4%

D2: gastrectomy with D2 lymph node dissection. PALN: para-aortic lymph node dissection.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.